Search research articles
Contact Us
Filters
Showing results (181-190 of 190) with videos related to
Page
of 19
Sort By:
You have reached the last page of results.
This site can display upto 190 results.
Journal of Immunology (Baltimore, Md. : 1950)
|
November 21, 2001
A novel mimetic antigen eliciting protective antibody to Neisseria meningitidis
D M Granoff, G R Moe, M M Giuliani, et al.
Leukemia
|
May 2, 2008
Telomerase inhibitor GRN163L inhibits myeloma cell growth in vitro and in vivo
M A Shammas, H Koley, R C Bertheau, et al.
Nature Biotechnology
|
March 30, 1999
Polymorphism identification and quantitative detection of genomic DNA by invasive cleavage of oligonucleotide probes
V Lyamichev, A L Mast, J G Hall, et al.
Leukemia
|
February 3, 2007
Novel etodolac analog SDX-308 (CEP-18082) induces cytotoxicity in multiple myeloma cells associated with inhibition of beta-catenin/TCF pathway
H Yasui, T Hideshima, H Ikeda, et al.
Oncogene
|
April 26, 2016
MMSET/WHSC1 enhances DNA damage repair leading to an increase in resistance to chemotherapeutic agents
M Y Shah, E Martinez-Garcia, J M Phillip, et al.
Leukemia
|
January 15, 2011
A unique three-dimensional SCID-polymeric scaffold (SCID-synth-hu) model for in vivo expansion of human primary multiple myeloma cells
T Calimeri, E Battista, F Conforti, et al.
Leukemia
|
September 21, 2007
Biological pathways and in vivo antitumor activity induced by Atiprimod in myeloma
P Neri, P Tassone, M Shammas, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 13, 2000
Sensitive detection of DNA polymorphisms by the serial invasive signal amplification reaction
J G Hall, P S Eis, S M Law, et al.
Leukemia
|
September 20, 2017
14-3-3ζ binds the proteasome, limits proteolytic function and enhances sensitivity to proteasome inhibitors
Y Gu, K Xu, C Torre, et al.
Leukemia
|
February 17, 2026
The evolution to hepta-refractory myeloma involves sequential loss of CD38, BCMA and GPRC5D
C Riedhammer, M Truger, H Lee, et al.
Page
of 19
Search research articles
Search
Showing results (181-190 of 190) with videos related to
Sort By:
Page
of 19
You have reached the last page of results.
This site can display upto 190 results.
Journal of Immunology (Baltimore, Md. : 1950)
|
November 21, 2001
A novel mimetic antigen eliciting protective antibody to Neisseria meningitidis
D M Granoff, G R Moe, M M Giuliani, et al.
Leukemia
|
May 2, 2008
Telomerase inhibitor GRN163L inhibits myeloma cell growth in vitro and in vivo
M A Shammas, H Koley, R C Bertheau, et al.
Nature Biotechnology
|
March 30, 1999
Polymorphism identification and quantitative detection of genomic DNA by invasive cleavage of oligonucleotide probes
V Lyamichev, A L Mast, J G Hall, et al.
Leukemia
|
February 3, 2007
Novel etodolac analog SDX-308 (CEP-18082) induces cytotoxicity in multiple myeloma cells associated with inhibition of beta-catenin/TCF pathway
H Yasui, T Hideshima, H Ikeda, et al.
Oncogene
|
April 26, 2016
MMSET/WHSC1 enhances DNA damage repair leading to an increase in resistance to chemotherapeutic agents
M Y Shah, E Martinez-Garcia, J M Phillip, et al.
Leukemia
|
January 15, 2011
A unique three-dimensional SCID-polymeric scaffold (SCID-synth-hu) model for in vivo expansion of human primary multiple myeloma cells
T Calimeri, E Battista, F Conforti, et al.
Leukemia
|
September 21, 2007
Biological pathways and in vivo antitumor activity induced by Atiprimod in myeloma
P Neri, P Tassone, M Shammas, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 13, 2000
Sensitive detection of DNA polymorphisms by the serial invasive signal amplification reaction
J G Hall, P S Eis, S M Law, et al.
Leukemia
|
September 20, 2017
14-3-3ζ binds the proteasome, limits proteolytic function and enhances sensitivity to proteasome inhibitors
Y Gu, K Xu, C Torre, et al.
Leukemia
|
February 17, 2026
The evolution to hepta-refractory myeloma involves sequential loss of CD38, BCMA and GPRC5D
C Riedhammer, M Truger, H Lee, et al.
Page
of 19